EAM Investors’s Amneal Pharmaceuticals AMRX Stock Holding History

EAM Investors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.84M	Buy	+337,663	New	+$4.63M	0.52%	75
2026 Q1	–	Sell	-425,718	Closed	-$5.36M	–	280
2025 Q4	$5.36M	Buy	+425,718	New	+$4.87M	0.6%	56
2023 Q4	–	Sell	-230,271	Closed	-$972K	–	240
2023 Q3	$972K	Buy	+230,271	New	+$859K	0.19%	247
2021 Q2	–	Sell	-259,873	Closed	-$1.75M	–	310
2021 Q1	$1.75M	Buy	+259,873	New	+$1.44M	0.26%	166

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

EAM Investors's AMRX Position: Q2 2026 in Review

EAM Investors opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 337,663 shares worth $5.84M. The stake represents 0.52% of the portfolio and ranks #75 among its holdings. This is a return to the name: EAM Investors previously reported a position in AMRX as recently as Q4 2025.

EAM Investors first reported a position in AMRX in Q1 2021 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

EAM Investors held 337,663 shares of Amneal Pharmaceuticals worth $5.84M as of Q2 2026.
Amneal Pharmaceuticals was a new EAM Investors position in Q2 2026.
Amneal Pharmaceuticals made up 0.52% of EAM Investors's portfolio in Q2 2026, its #75 holding.
EAM Investors first reported a position in Amneal Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.